|
|
| SN |
Author |
Title |
Status |
| 1751 |
karnal |
ADVANTAGES AND APPLICATIONS OF NANOPARTICLE DRUG DELIVERY SYSTEM: A COMPREHENSIVE REVIEW |
Under Review |
| 1752 |
Roshani M. Gharat |
QUALITY CONTROL AND QUALITY ASSURANCE OF TELMISARTAN TABLETS: A COMPREHENSIVE REVIEW |
Under Review |
| 1753 |
Yogita Warghade |
“LEMONGRASS: “A COMPREHENSIVE REVIEW OF IDENTIFICATION, AUTHENTICATION, EXTRACTION, EVALUATION, AND STANDARDIZATION METHOD.” |
Under Review |
| 1754 |
Jayashri H. Zaware |
“THE ETHNOMEDICINAL HERITAGE OF TRIDAX PROCUMBEN: A CRITICAL EVALUATION OF TRADITIONAL USES AND SCIENTIFIC EVIDENCE.” |
Under Review |
| 1755 |
S. Bhattacharjee |
ASPRIN TABLETS' MATRIX FORMS: FORMULATION, EVALUATION AND COMPARATIVE PREFORMULATION STUDY USING VARIOUS NATURAL POLYMERS |
Accepted |
| 1756 |
Jesindha |
HARNESSING BUSINESS INTELLIGENCE IN PHARMACEUTICAL INDUSTRY |
Accepted |
| 1757 |
pranita |
A REVIEW ON THERAPEUTIC, TRADITIONAL, AND INDUSTRIAL APPLICATIONS
OF ARGEMONE MEXICANA |
Under Review |
| 1758 |
pranita |
A REVIEW ON THERAPEUTIC, TRADITIONAL, AND INDUSTRIAL APPLICATIONS
OF ARGEMONE MEXICANA |
Under Review |
| 1759 |
pranita |
A REVIEW ON THERAPEUTIC, TRADITIONAL, AND INDUSTRIAL APPLICATIONS
OF ARGEMONE MEXICANA |
Under Review |
| 1760 |
Neha C. Patil |
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF PROMETHAZINE HCL IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM |
Under Review |
| 1761 |
Karthik K. |
THE ROLE OF MALNUTRITION IN TUBERCULOSIS SUSPECTIBILITY AND RECOVERY |
Under Review |
| 1762 |
mahesh |
FORMULATION AND EVALUATION OF HERBAL SHAMPOO BY USING SHIKHAKAI |
Under Review |
| 1763 |
shivam |
FORMULATION AND ASSESSMENT OF HERBAL CHOCOLATE INFUSED WITH ARJUNA BARK FOR HEART HEALTH |
Under Review |
| 1764 |
Shafia Sultana |
ORGANIC CHEMISTRY IN SUNSCREEN |
Accepted |
| 1765 |
Shafia Sultana |
SWEET MOLECULES: EXPLORING THE ORGANIC CHEMISTRY BEHIND ARTIFICIAL SWEETENERS |
Accepted |
| 1766 |
Vaishnavi Narawade |
NATURAL ALTERNATIVES TO PLASTIC WRAPPERS IN DISPOSAL OF SANITARY PADS: A REVIEW |
Accepted |
| 1767 |
MUNEESWARAN |
Green synthesis of Bovine Serum Albumin conjugated Silver Nanoparticles from the Aqueous leaf extract of Jatropha glandulifera Roxb. (Euphorbiaceae) and evaluation of Anti-microbial activities |
Rejected |
| 1768 |
MUNEESWARAN |
GREEN SYNTHESIS OF BOVINE SERUM ALBUMIN CONJUGATED SILVER NANOPARTICLES FROM THE AQUEOUS LEAF EXTRACT OF JATROPHA GLANDULIFERA ROXB. (EUPHORBIACEAE) AND EVALUATION OF ANTI-MICROBIAL ACTIVITIES |
Under Review |
| 1769 |
pranjal |
A REVIEW OF THERAPEUTUC AGENTS IN CERVICAL CANCER: FROM CHEMOTHERAPY TO TARGETED THERAPY AND IMMUNOTHERAPY |
Under Review |
| 1770 |
Trupti |
ACACIA NILOTICA AS MULTI-PURPOSE MEDICINE PLANT: A COMPLETE REVIEW OF ITS BIOACTIVE PROPERTIES |
Accepted |
| 1771 |
kalpesh |
REVIEW ON APOPTOSIS AND ITS ROLE IN HEALTH |
Under Review |
| 1772 |
joseph |
Clinical Spectrum and Management of Penile Abscess: Case Series. |
Accepted |
| 1773 |
ABHIJIT |
Role of nanotechnology in drug delivery systems |
Under Review |
| 1774 |
Tulja |
AN OVERVIEW: BENEFICIAL ROLE OF PITHECELLOBIUM DULCE IN HUMAN HEALTH |
Under Review |
| 1775 |
Sushanta |
ASSOCIATION OF INSULIN RESISTANCE WITH POLYCYSTIC OVARY SYNDROME |
Accepted |
| 1776 |
Dhilip Kumar M. |
A COMPREHENSIVE REVIEW ON DIABETIC NEUROPATHY AND ITS CLINICAL IMPLICATIONS |
Accepted |
| 1777 |
M.N.Gokulavanisri |
THE BLISS MOLECULE ANANDAMIDE: A NEUROPHARMACOLOGICAL PERSPECTIVE ON HOLISTIC STRESS MANAGEMENT THROUGH A LIFESTYLE-BASED CONCEPTUAL RESEARCH FRAMEWORK |
Accepted |
| 1778 |
MAHALAKSHMI |
ALAGILLE SYNDROME BEYOND CHILDHOOD: A BIBLIOMETRIC AND CLINICAL REAPPRAISAL OF A RARE GENETIC DISORDER. |
Accepted |
| 1779 |
saurabh |
AI CONVERGENCE IN DRUG DEVELOPMENT AND RESENT APPLICATION |
Under Review |
| 1780 |
Railan |
SOP OF PHARMACEUTICAL COMPANY |
Under Review |
| 1781 |
Shivampeta Ruchita |
DESIGN AND DEVELOPMENT OF NATIONAL DRUG REGULATORY SYSTEM AND POLICIES |
Accepted |
| 1782 |
V |
REVIEW ON MEDICINAL PROPERTIES, WOOD CHARACTERISTICS AND ITS POTENTIAL UTILIZATION OF ADINA CORDIFOLIA (ROXB.) BRANDIS |
Accepted |
| 1783 |
Ravi Raj |
A COMPARATIVE LITERARY, ANALYTICAL, PHARMACOLOGICAL AND CLINICAL EVALUATION OF 500 MG POLYHERBAL FORMULATION CAPSULE FOR DIABETES MANAGEMENT ; PHYTOCHEMICAL PROFILING, MECHANISTIC INSIGHTS, AND THERAP |
Accepted |
| 1784 |
Chaitra |
EVALUATION OF TURMERIC WATER AND SALT WATER IN REDUCING IMIDACLOPRID RESIDUE IN CAPSICUM ANNUUM |
Accepted |
| 1785 |
A. Rubini |
DIURETIC ACTIVITY OF ETHANOLIC PLANT EXTRACTS OF CLEOME GYNANDRA IN ALBINO WISTAR RATS |
Accepted |
| 1786 |
Ravivarma |
SUNVOZERTINIB: A NEXT-GENERATION TARGETED THERAPY FOR EGFR EXON 20 INSERTION–MUTATED NON-SMALL CELL LUNG CANCER |
Under Review |
| 1787 |
saravana |
TOXICITY ASSESSMENT OF AZITHROMYCIN: INSIGHTS FROM THE SILKWORM EXPERIMENTAL MODEL |
Accepted |
| 1788 |
Shaik Sameer |
Datopotamab Deruxtecan in Oncology: Emerging Evidence in Lung and Breast Cancer Therapy
|
Under Review |
| 1789 |
Hamad M Adress Hasan |
EFFECT OF ALCOHOLIC AND AQUEOUS SOLVENTS ON DETECTION AND QUANTITIES OF PHENOLIC COMPOUNDS OF LEAVES AND STEMS OF GLOBULARIA (GLOBULARIA REPENS) BY USING GC-MASS METHOD |
Accepted |
| 1790 |
P. Sivasubramaniyan |
REVIEW ON LEUCAS ASPERA |
Accepted |
| 1791 |
Anni Selviya |
CURRENT DEFICIENCIES IN SCHEDULE Y |
Accepted |
| 1792 |
V. Varalakshmi |
PRINCIPLES AND GUIDELINES FOR REGULATORY AFFAIRS OF PHARMACEUTICAL PRODUCTS |
Accepted |
| 1793 |
Karam Anilkumar |
REGULATORY STRATEGY FOR FILING NDA /ANDA |
Accepted |
| 1794 |
saurabh |
AI CONVERGENCE IN DRUG DEVELOPMENT AND RECENT APPLICATION |
Under Review |
| 1795 |
saurabh |
AI CONVERGENCE IN DRUG DEVELOPMENT AND RECENT APPLICATION |
Under Review |
| 1796 |
A.Jhansi Rani |
CURRENT REGULATIONS FOR HERBAL PRODUCTS |
Accepted |
| 1797 |
Santhosh Kumar Reddy |
SIMILARITIES AND DIFFERENCE BETWEEN US DMF, CANADIAN DMF AND EDMF |
Accepted |
| 1798 |
Yogita |
"HERBAL AND BOTANICAL AGENTS IN THE TREATMENT OF MELASMA : A REVIEW OF INGREDIENTS DEVLOPMENTS & EVALUATION" |
Accepted |
| 1799 |
Ambili |
REVIEW ON MICROENCAPSULATION |
Accepted |
| 1800 |
Valluri Sowmya |
PATENT ISSUES IN ANDA APPROVAL |
Accepted |
|
|
